| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Casein kinase I isoform delta |
|---|
| Ligand | BDBM50362709 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_798419 (CHEMBL1944167) |
|---|
| IC50 | 320±n/a nM |
|---|
| Citation |  Ho, GD; Yang, SW; Smotryski, J; Bercovici, A; Nechuta, T; Smith, EM; McElroy, W; Tan, Z; Tulshian, D; McKittrick, B; Greenlee, WJ; Hruza, A; Xiao, L; Rindgen, D; Mullins, D; Guzzi, M; Zhang, X; Bleickardt, C; Hodgson, R The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia. Bioorg Med Chem Lett22:1019-22 (2012) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Casein kinase I isoform delta |
|---|
| Name: | Casein kinase I isoform delta |
|---|
| Synonyms: | CKI-delta | CKId | CSNK1D | Casein kinase 1 delta (CK1δ) | Casein kinase I delta | Casein kinase I isoform alpha/delta | Casein kinase I isoform delta (CK1D) | HCKID | KC1D_HUMAN | casein kinases 1 delta (CK1 delta) |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 47356.76 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P48730 |
|---|
| Residue: | 415 |
|---|
| Sequence: | MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ
GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH
SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA
SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL
CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRA
ADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPV
SGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR
|
|
|
|---|
| BDBM50362709 |
|---|
| n/a |
|---|
| Name | BDBM50362709 |
|---|
| Synonyms: | CHEMBL1939782 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C17H21N5O |
|---|
| Mol. Mass. | 311.3815 |
|---|
| SMILES | COc1cc(C)c2nc3[nH]nc(C)c3c(N3CCNCC3)c2c1 |
|---|
| Structure | 
|
|---|
Search and Browse
